A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...

The FDA has approved Yeztugo, a twice-yearly HIV injection by Gilead shown to virtually eliminate new infections.

Pharma/biotech giants Pfizer PFE and Bristol Myers BMY boast of a dominant position in the lucrative oncology space. Oncology ...

After months of waking up with headaches, Claire visited her GP. Her life was turned upside down as doctors discovered what ...

Experts align on several aspects of intralesional corticosteroid techniques for alopecia in a national survey.

The auto-injectors market is forecast to reach a value of USD 5.71 billion in 2025 and is expected to expand to USD 23.31 billion by 2035, growing at a steady compound annualgrowth rate of 8.2% over ...

From migraine to Parkinson’s and obesity, AbbVie is building dominant franchises across multiple high-growth areas. Read why ...

In June 2025, Carmot Therapeutics Inc. announced a Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of ...

Discover why Tonix Pharmaceuticals Holding Corp. stock could rally with FDA approval for Tonmya targeting fibromyalgia. Click ...

Major players in the lead poisoning treatment market include Pfizer Inc., Johnson & Johnson Services Inc ... announced the approval and commercial launch of Edetate Calcium Disodium Injection, a ...

Pharmacies will now serve as the new frontline for contraceptive access following a new initiative aimed at expanding services to the private sector.